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Up-regulation of tau, a brain microtubule-associated protein, in lens
cortical fractions of aged αA-, αB-, and αA/B-crystallin knockout
mice
Fang Bai, Jing-hua Xi, Usha P. Andley
Department of Ophthalmology and Visual Sciences, and of Biochemistry and Molecular Biophysics, Washington University School
of Medicine, St. Louis, MO
Purpose: α-Crystallin is expressed at high levels in the lens in a complex of αA- and αB-crystallin subunits in 3:1 molar
ratios, and is known to maintain the solubility of unpolymerized tubulin and enhance the resistance of microtubules to
depolymerization, but its effect on proteins classically associated with microtubule stability (microtubule associated proteins) in the lens is unknown. In the present study we examined the expression of the brain microtubule associated protein
tau in lenses of α-crystallin gene knockout mice.
Methods: Quantitative RT-PCR, immunoblotting, cryo-immunoelectron microscopic and immunohistochemical methods were used to characterize the expression of tau in the lenses of αA-/--, αB-/--, and αA/B-/--crystallin mice.
Results: Immunoreactivity to tau, a 45-66 kDa brain microtubule associated protein that has been best characterized in
neurons and neuronal pathologies, was uniquely upregulated in lens cortical fiber cells with aging and was associated with
the microtubule fraction of αA-/--, αB-/--, and αA/B-/--crystallin mouse lenses, but was undetectable in wild type lenses.
Quantitative RT-PCR analysis further showed an upregulation of tau transcripts in αA-/-- and αA/B-/--crystallin lenses.
Brain microtubule fractions served as a positive control for tau in these experiments. An increase in phosphorylation of tau
was detected in αA-/-- and αB-/--crystallin brain proteins.
Conclusions: Although tau aggregation and αB-crystallin expression have been shown to increase in neurodegenerative
diseases, surprisingly tau expression increases in the α-crystallin knockout lenses, suggesting that αA- and αB-crystallins
are potentially important regulators of tau expression in lens.

tallin are thought to selectively recognize and bind to exposed
surfaces of a nonnative protein, in a noncovalent interaction
to inhibit irreversible aggregation [13-15]. αB-Crystallin has
also been shown to participate in the degradation of misfolded
proteins that cannot be converted into the native state after
repeated cycling through the chaperone systems, allowing recognition of the incompletely folded protein by an E3 ubiquitin
ligase and subsequent targeting of the misfolded protein for
degradation by the proteasome [16,17]. The role of αB-crystallin in proteasomal targeting has also been shown during
normal cellular processes, as illustrated by degradation of
cyclin D1 during the cell cycle [17].
The brain microtubule associated protein tau, known to
stabilize the microtubule cytoskeleton and promote microtubule assembly, is a group of 45-66 kDa proteins encoded by
alternative splicing of a single gene [18]. There are six predominant tau isoforms in human brain containing 352-441
amino acids [19]. The tau proteins are unstructured in solution but bind in an ordered conformation along the microtubule protofilaments to stabilize and/or strengthen interactions
between adjacent protofilament and increase microtubule integrity [20]. Aggregation of tau into paired helical filaments
via hyperphosphorylation is the main component of neurofibrillary tangles found in the brains of Alzheimer disease
(AD) patients [21-23]. Tau is thought to be associated with
the primary pathology and neuronal damage in tauopathies

The vertebrate lens is composed of a single layer of epithelial cells on its anterior surface, which divide and differentiate in the equatorial zone, and undergo elongation, and nuclei and organelle degradation [1,2]. This orderly process continues throughout life, and is thought to be responsible for
maintaining a transparent lens. The lens fiber cells have a limited ability to turnover proteins as the lens ages. α-Crystallin,
a major protein of lens fiber cells, is a member of the small
heat shock protein family of chaperones, and is isolated from
the lens as a complex of αA- and αB-crystallin subunits in
3:1 stoichiometry [3]. The α-crystallins are expressed very
early during lens development [4]. Both αA- and αB-crystallin have been shown to be expressed in tissues outside the
lens including brain [5,6]. The αB-crystallin subunit is a stressinduced protein that is widely expressed in tissues outside the
lens, whereas the αA-crystallin subunit is more lens-specific
and is not stress inducible [7-9]. Recent work suggests that
αA- and αB-crystallin play a role in development and growth
by interacting with components of cellular protein degradation machinery and maintaining the cytoskeleton, thereby regulating diverse cellular processes [10-12]. αA- and αB-crysCorrespondence to: Usha P. Andley, Ph.D., Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8096, St. Louis, MO, 63110;
Phone: (314) 362-7167; FAX: (314) 362-3638; email
andley@vision.wustl.edu
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like frontotemporal dementia (FTDP) [24-26]. The molecular
chaperone/stress-inducible small heat shock protein αB-crystallin is known to be upregulated in astrocytes associated with
senile plaques and cerebral amyloid angiopathy in AD [27,28].
αB-Crystallin is also associated with Lewy body disease,
Parkinson disease, multiple sclerosis, FTDP and other
neurodegenerative disorders [28-30]. The specific role of αBcrystallin in these disorders is unknown. Investigators have
detected an early defining feature of Alzheimer disease, the
Aβ peptides in the cytosol of the lens fiber cells, and suggested that the Aβ-mediated aggregation of lens proteins contributes to increased light scattering in the lens [31,32]. Indeed, several studies suggest protein-protein interactions between αB-crystallin and Aβ [33,34]. αB-Crystallin has also
been shown to inhibit the aggregation of small Aβ peptides
into mature fibrils in vitro [35]. Furthermore, studies by
Frederikse et al. [36] on microtubules and kinesin based transport in the lens suggest several fundamental parallels between
lens and neuronal vesicle trafficking and cell biology, and suggest that Aβ-related vesicle trafficking disease mechanisms
may be shared by lens and brain.
The microtubule cytoskeleton is a very dynamic network
that plays a crucial role in key biologic processes such as cell
division and intracellular traffic [37]. Microtubule dynamic
instability and functions are regulated by microtubule-associated proteins (MAPs). αB-Crystallin enhances microtubule
resistance to depolymerization, and maintains tubulin levels
in vivo in muscle cells [38,39]. Our previous studies with αA, αB- and αA/B-crystallin gene knockout mice suggested that
the depletion of these chaperones is associated with changes
in cell cycle parameters, and more specifically, a microtubule
instability phenotype [40-43]. We therefore investigated the
expression of the brain MAP tau, known to enhance microtubule stability, in microtubule fractions from αA- and αB-crystallin gene knockout mice in the current work. Surprisingly,
in the αA- and αB-crystallin gene knockout mice we found
that the tau is uniquely upregulated in the differentiated lens
cortical fiber cells, which have a limited ability to turnover
protein as the lens ages. Our results demonstrate that the lens
is an important organ that can capture some of the systemic
pathology involved in protein aggregation disorders that affect the brain, and suggest that the α-crystallin knockout mice
may be a good model to study disease mechanisms involving
protein aggregation in the brain.
METHODS
Animals and tissues: Wild type and αA-/--, αB-/--, and αA/B-/
- knockout mice were used in this study. Wild type mice were
the 129SvEv strain from Taconic Farms (Hudson, New York).
The crystallin knockout mice αA-/--, αB/HSPB2-/-- (termed αB/- in this study) and αA/αB/HSPB2-/-- (termed αA/B-/-- in this
study) were kindly provided by E. Wawrousek (National Eye
Institute, NIH, Bethesda, MD) [44,45]. αB-Crystallin has also
been termed HSPB5 [46]. Mice were inbred and all animal
protocols were in accordance with the institutional policy on
the use of animals in research [40,41]. Mice were used at 1 to
12 months of age. At the appropriate age, animals were killed

by CO2 inhalation. Whole eyes were dissected, fixed and sectioned for immunofluorescent detection of tau. Whole lenses
were dissected and epithelial and cortical fractions (Figure 1A)
were isolated under a microscope, and were used to prepare
microtubules and microtubule associated proteins as described
previously [42,43]. Lens cortical fractions were used for RNA
isolation. Brains collected from the mice of each genotype
were also used.
Antibodies: The following tau antibodies were used for
immunoblot, immunofluorescence and cryo-immuno electron
microscopic (em) analysis: (1) KAM- MA305 (Stressgen, Ann

Figure 1. Preparation of microtubule associated proteins. A: Dissection of mouse lens epithelial and cortical fractions used for the isolation of microtubule associated proteins (MAPs). Wild type, αA-/--,
αB-/--, and αA/B-/-- lenses were dissected into epithelial (blue) and
cortical fiber cell (red) fractions. Microtubules were reconstituted
from lens cortical fiber cell lysates and MAPs were extracted as described under Experimental Procedures. B and C: Electron micrographs of mouse lens cortical fiber microtubules that were used to
dissociate the MAPs. Microtubules were negatively stained and examined. B shows wild type microtubules and C shows αB-/-- microtubules. The scale bar is equal to 50 nm.
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Arbor, MI) at 1:1000 dilution for immunoblotting, and 1:100
for cryo-immuno em and immunofluorescence; (2) AT8 antibody to PHF-tau (Pierce, Rockford, IL) at 1:40 dilution for
immunoblotting and immunofluorescence, and 1:5 for
cryoimmuno electron microscopy [47]; (3) TAU-5 (Lab Vision, Fremont, CA) at 1:200 dilution for immunoblotting and
1:5 for cryoimmuno electron microscopy [48-50]; (4) pS422
(Biosource, Carlsbad, CA) at 1:1000 dilution [48].
Quantitative reverse transcriptase polymerase chain reaction (RT-PCR): Total RNA from wild type and knockout
(αA-/--, αB-/--, and αA/B-/--) was isolated from mouse lens cortical fractions and mouse brain fractions by the Qiagen kit.
One µg of total RNA was used for each sample to prepare
cDNA. The RNA was treated with DNase and first strand
cDNA synthesis was performed using a kit from Invitrogen
using Oligo(dT) as primer. Primers were designed and synthesized by Integrated DNA Technologies (Coralville, IA).
Their concentrations optimized using the manufacturer’s recommendations. The forward and reverse primers used for
mouse tau gene are shown in Figure 2. To optimize the primers, reverse-transcriptase polymerase chain reaction (RT-PCR)
was performed and products were run on 1.5% agarose gels to
ascertain that a single band of the correct size was obtained.
Real time-PCR was performed using a supermix containing
the fluorescent dye SYBR green (BioRad, Hercules, CA) as
described previously [51]. The increase in fluorescence was
detected using the iCycler (BioRad). The relative quantification of tau gene expression was performed using the standard

©2007 Molecular Vision

curve method according to manufacturer’s instructions
(BioRad). For comparison between wild type and knockout
samples, a standard curve of cycle thresholds for several serial dilutions of RNA sample was established and then used to
calculate the relative abundance levels of mRNA (mRNA).
The expression level of each tau mRNA was determined relative to GAPDH of the same sample. All RT-PCR reactions
were performed in triplicate, and three independent experiments were performed on lens and brain samples.
Isolation of microtubule associated proteins: Microtubules were reconstituted from freshly dissected mouse lens
epithelial and cortical fractions (Figure 1) [42,52]. Briefly, lens
cortical fraction pooled from 16 to 20 mouse lenses was homogenized in 100 µl PME buffer (80 mM PIPES, 1 mM MgCl2,
1 mM EGTA, pH 6.8) at 4 °C, followed by centrifugation at
30,000g for 15 min and the resulting supernatants were centrifuged at 100,000g for 60 min in a Beckman Optima TLX
ultracentrifuge. Taxol (20 µM) and GTP (1 mM) were added
to the supernatants, and incubated for 15 min at 37 °C, followed by centrifugation at 30,000 g for 15 min at 37 °C through
a sucrose cushion to pellet the microtubules. Microtubule associated proteins were extracted by washing the pellets in 0.35
M NaCl, and centrifugation at 30,000g for 25 min. This procedure has been shown to extract the MAPs in the supernatant
[52]. Microtubules were examined by electron microscopy on
negatively stained microtubule pellets as described previously
[42]. To analyze tau expression in the brain, wild type and
αA-/--, αB-/--, or αA/B-/-- brains were homogenized in PME

Figure 2. Transcripts for mouse tau. The three major tau transcripts were designated Tau-2, Tau-4, and Tau-6. The Ensembl transcript
ENSMUST00000018555 was used to design gene-specific primers. Exons are indicated by vertical lines. Horizontal arrows indicate the sites
for sequence-specific primers. The following nucleotides correspond to the primers: Exon 2 forward primer: nucleotide +12 to +35; Exon 4
forward primer: nucleotide +431 to +456; Exon 6 forward primer: nucleotide +905 to +928; Exon 7 reverse primer: antisense of nucleotide
+1268 to +1245.
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buffer and microtubule associated proteins were isolated as
described above for lens tissue.
Gel electrophoresis and immunoblot analysis: Supernatants containing MAPs were analyzed by SDS-PAGE and
immunoblotting, using several commercially available antibodies to tau described above. Proteins were separated using

©2007 Molecular Vision

SDS-PAGE as described previously [42,53,54]. Samples were
heated to 95 °C in sample buffer for SDS-PAGE. In experiments on brain tissue, better visualization of proteins in
immunoblots was obtained when temperature was lowered to
85 °C. To examine the expression of tau in MAP fractions of
wild type and knockout lens cortical fiber cells, equal amount

Figure 3. Immunoblot analysis of tau in mouse lens. Lens cortical fiber cell MAPs from 8-month-old wild type, αA-/-- and αB-/-- mice were
prepared and the proteins were separated by SDS-PAGE. Tissue from 16 to 20 lenses was pooled for each preparation. Samples were heated
to 95 °C in SDS-PAGE sample buffer to detect tau in lens samples. Immunoblot analysis was performed with the monoclonal antibody KAMMA305 to full length brain tau protein and the Tau-5 antibody which reacts with nonphosphorylated as well as phosphorylated forms of tau.
A: Antibody used was KAM-MA305 to full length brain tau. Left panel, Wild type (WT) and αA-/-- MAPs. Tau was undetectable in the wild
type lenses, but tau immunoreactive proteins were detected in the 45-66 kDa range in the αA-/-- and αB-/-- lens fractions. Note that the αA-/-- tau
immunoreactive bands included a prominent 100 kDa band; middle panel, WT and αB-/-- MAPs. Tau immunoreactivity was undetectable in
the wild type MAPs from cortical fiber cells, but higher molecular weight crosslinked bands (asterisks) crossreacted with the antibody in the
αB-/-- MAPs. Right panel, Microtubule associated proteins were isolated from 3-month-old mouse brains and analyzed by SDS-PAGE and
immunoblotting. Note that the major immunoreactive bands were detected at 45-66 kDa, whereas minor bands were detected at about 100
kDa. B: Human cells-34 lysates were analyzed with the KAM-MA305 antibody. Tau immunoreactive bands at about 100 and 200 kDa bands
were prominent in these cells. C: Antibody used was the Tau-5 antibody which recognizes both nonphosphorylated and phosphorylated forms
of tau; left panel, Immunoreactivity of wild type and αA/B-/-- lens fractions. Although no immunoreactive bands were detected in the wild type
lens, a broad band was observed in the αA/B-/-- lens; right panel, wild type brain fractions run on the same gel with a similar broad band
showing immunoreactivity to this antibody.
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of total protein was loaded from each sample. Immune complexes were detected using a horseradish peroxidase labeled
secondary antibody and luminol (Santa Cruz Biotechnology,
Santa Cruz, CA). The detected proteins were quantified with
an Alpha Innotech photoimaging system (San Leandro, CA)
[42].
Immunolabeling and confocal microscopy of the microtubule associated protein tau: To examine tau immunolabeling
in the lens, wild type and α-crystallin knockout eyes were
fixed and mounted in glycol methacrylate [41,43]. Three micron sections were cut in the mid-sagittal plane [41]. Nonspecific binding was blocked by incubation with normal goat serum for 30 min. To visualize the distribution of tau, tissues
were incubated overnight with a 1:100 dilution of an antibody
to tau, and an Alexa-568-conjugated secondary antibody
(1:200). Immunofluorescence and confocal microscopy were
performed in the red channel of a Zeiss 510 confocal microscope. Differential interference contrast (DIC) was used to
examine morphology in the blue channel of the confocal microscope [41].
Cryoimmuno electron microscopic analysis: Lens sections were examined by cryo-immuno electron microscopy.
Sections (50-80 nm) were treated with primary antibodies to
tau KAM-MA305 (Stressgen) and Tau-5 (Laboratory Vision)
and anti-mouse IgG conjugated with 18 nm gold particles as
secondary antibody (Sigma, St. Louis, MO). Specimens were
stained with uranyl acetate and examined in a 1200EX transmission electron microscope as described previously [55,56].
UVB irradiation of lenses: Wild type 129SvEv mice were
irradiated with FS20 UVB lamps emitting 290-320 nm radiation (maximum output at 310 nm) at a fluence rate of 7.8 W/
m2 for 60 min, with a total fluence of 28 kJ/m2 at the cornea
[57]. Twenty-four h later, mice were sacrificed and eyes were
dissected and sectioned. Tau expression was visualized in control and UVB-exposed lenses by immunofluorescence analysis using antibodies to tau, and sectioned were examined by
confocal microscopy.
RESULTS
Previous studies on gene knockout models of αA- and αBcrystallin suggested a decrease in lens microtubule stability
[42]. As a first step to verify this observation, we examined
the expression of the tau, a brain microtubule-stabilizing protein, in the lens. Lens cortical fractions were dissected (Figure
1A) and microtubule fractions were isolated (Figure 1B,C).
More clusters appear to be associated with αB-/-- microtubules
than wild type as described previously [42].
Expression of tau protein in lens fiber cells: Lens microtubule fractions containing microtubules and MAPs were examined for tau protein expression by immunoblotting using
an antibody made against full-length brain tau protein. Tau
immunoreactivity was undetectable in the wild type lens MAP
fractions. Tau immunoreactive bands at the expected mobilities were observed in αA-/-- lens cortical fiber cells of mice 6
months of age and older (Figure 3) A distinct band of slower
electrophoretic mobility corresponding to a molecular mass
of 100 kDa was also detected in the αA-/-- lens fractions. In

addition, a group of significantly weaker bands of about 200
kDa were detected in the αA-/-- lens fractions (Figure 3). The
αB-/-- lens fractions also demonstrated immunoreactivity to
the tau antibody in the 45-66 kDa range. Two bands having
lower electrophoretic mobilities, and about 100 kDa and 200
kDa mass crossreacted with the tau antibody in the αB-/-- lens
fractions. We used brain MAP preparations as positive control for the antibody against tau that was run together with the
lens samples for comparison (Figure 3). Mouse brain MAPs
showed strong tau immunoreactivity with distinct 45-66 kDa
proteins, suggesting that the 45-66 kDa bands in the lens
samples are unlikely to be nonspecific artifacts that cross react with the tau antibody. In addition, the brain fractions expressed a weaker tau immunoreactive band at 100 kDa. We
also used a positive antibody control, human cells-34. These
cells are known to produce tau in abundance. Immunoreactive bands to tau were observed both in the 45-66 kDa as well

Figure 4. Immunofluorescence analysis of tau in the lens. Anti-tau
immunostaining in lens sections from 6-month-old-mice. Red=tau;
blue=DIC. A: Wild type lens. B: αA/B-/-- lens. C: αB-/-- lens. D: Absence of immunofluorescence in the lens specimen of a 6-month-old
αA/B-/-- lens probed with non-immune mouse IgG. The scale bar is
equal to 25 µm. E: Dark field image of a 6-month-old wild type
mouse lens. F: Dark field image of a 6-month-old αA/B-/-- lens. Note
that the opacity occupies three quarters of the lens. Note also that the
outer cortex of the αA/B-/-- lens remains relatively clear.
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as about 100 and 200 kDa molecular mass range. To further
establish that the proteins detected with the KAM antibody
were indeed tau, a previously well characterized tau antibody
(Tau-5) against brain tau was also used. This antibody which
detects both non-phosphorylated and phosphorylated tau proteins detected a strong broad band in the 45-66 kDa range in
the αA/B-/-- but not the wild type lens, and in the wild type
brain (Figure 3C). Similar results were obtained with lens fractions of αA-/-- and αB-/-- lenses (data not shown).
The distribution of tau immunoreactive proteins was examined by immunofluorecence and confocal microscopy. Lens
sections from wild type and αA/B-/-- mice were treated with
an antibody to tau and examined by confocal microscopy. Figure 4 shows a strong increase in immunofluorescence of the
αB-/-- lenses as compared with wild type lenses (Figure 4AC). Figure 4C also shows that the distribution of tau in the
cortical fiber cells of αB-/-- lenses appears to follow the lens
fiber cell length. Replacement of the primary antibody with a
non-immune mouse IgG and normal rabbit serum did not result in immunofluorescence staining (Figure 4D). These data
suggest that our results are not attributable to non-specific staining artifact. Although tau immunoreactivity was observed in
newly formed cortical fiber cells (Figure 4B,C), it was not
detectable in the inner nuclear fibers, where where lenses of
αA/B-/-- mice develop nuclear cataract (Figure 4E,F). To further confirm the increase in expression of tau in the αB-/-mouse lenses, cryo-immunoelectron microscopy was employed. Figure 5A,B show cryo-immunolabeling of tau in wild
type and αB-/-- mouse lens cortical fiber cells, respectively.
Very sparse background labeling was observed in the wild type
lens cortical fiber cells with the KAM antibody. In contrast,

the αB-/-- lens cortical fibers showed abundant labeling, with
clusters of immunogold particles in electron dense regions.
Figure 5C,D show the immunolabeling of lens cortical fibers
with the Tau-5 antibody. A vast increase in labeling was observed in the αB-/-- lenses whereas wild type lenses showed
no labeling. These data confirm the upregulation of tau in the
αB-/-- lens cortical fiber cells.
A developmental time course for the appearance of tau
immunoreactive proteins in mouse lens cortical fiber cells was
performed. Figure 6 shows the effect of mouse age on expression of tau immunoreactivity in αA-/--, αB-/--, and αA/B-/-lenses. In lenses of mice less than 4 months old, no tau isoforms
(45-66 kDa) were detectable by immunoblot analysis. Tau expression stabilized in lens fractions derived from mice older
than 6 months of age. These results indicate that the change in
tau immunoreactivity in lens cortical fiber cells of α-crystallin gene knockout mice occurs around six months of age. A
parallel study in lens epithelial cells with age showed that the
expression of tau immunoreactivity was very weak in wild
type or αA-/--, αB-/--, and αA/B-/-- epithelial fractions (data not
shown). Taken together, the immunoblot, immunofluorescence
and cryo immunoelectron microscopic analysis indicated that
the loss of chaperones αA- and αB-crystallins resulted in enhancement of tau immunoreactive proteins in the differentiated lens cortical fiber cells.
Transcriptional activity of tau in the lens: We next examined the expression of tau transcripts in the lenses of wild
type and α-crystallin gene knockout mice. Tau is encoded via
the transcription of a single gene by alternative splicing [18,23].
We designed primers specific to sequences in tau gene encoding the major tau peptides (Figure 2). Transcriptional activity
Figure 5. Cryo-immuno electron microscopy of tau in the lens. Anti-tau
cryo-immuno electron microscopy in
lens sections from 8-month-old mice
with the antibody KAM-MA305 (A and
B) or Tau-5 (C and D). A: Absence of
cryo-immuno labeling in the lens cortical fiber cells of an 8-month-old wild
type mouse. B: αB-/-- lens shows ample
immunostaining with the tau antibody
KAM-MA305, with clusters of
immunogold particles in electron dense
areas of the cells (arrows). C: Absence
of immunostaining in 7-month-old wild
type lens. D: αB-/-- lens shows ample
immunostaining with the tau-5 antibody, with numerous immunogold particles in lens fiber cells (arrows). All images are shown at the same magnification. The scale bar is equal to 0.5 µm.
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of tau gene in the lens was confirmed by RT-PCR (Figure 7).
A 187 bp fragment was amplified using a pair of gene-specific primers designed to anneal to sequences associated with
the Tau-2 transcript (Figure 2). This was the major tau transcript detected in the lens, and corresponded to expression of
the smallest mouse tau peptide with 372 amino acid residues
(Figure 2). Primers specific to the alternatively spliced Tau-4
transcript encoding the medium-length (432 residues) tau protein amplified a 127 bp PCR product in the brain (Figure 8)
but not in the lens (Figure 7), suggesting that this transcript is
not expressed in the lens. Similarly, a 364 bp PCR product
was amplified from primers sequences designed to amplify
the transcript encoding the longest tau peptide (733 residues)
in the lens (Figure 7). Quantitative RT-PCR reactions were
performed to assess the effect of αA- and αB-crystallin gene
knockout on tau gene expression. GAPDH gene expression
was used as a control. This analysis confirmed the expression
of the Tau-2 transcript in the wild type lenses, and showed
that this transcript was uniquely upregulated by 2.5 fold in the
αA-/-- and a nearly fivefold in αA/B-/-- lenses, but not in αB-/- lenses (Figure 7B). In contrast, the Tau-4 transcript was undetectable in lenses of any genotype. Although the Tau-6 transcript encoding the largest tau peptide was undetectable in the
wild type and αB-/-- lenses, it was strongly upregulated in the
αA-/-- and αA/B-/-- lenses. However, the relative abundance of
the Tau-6 transcript was one tenth of the Tau-2 transcript in
the αA-/-- and αA/B-/-- lenses. Tau transcripts were also examined in the lenses of 1 month old mice (data not shown). The
tau transcripts were expressed at one fourth the levels in young
(1 month old) as compared with old (6 months old) mice. The
ratio of Tau-2/GAPDH transcripts was 0.3±0.05 in young
lenses, increasing to 1.44±0.26 in 6 month old lenses.
Expression of tau in mouse brains: To ascertain unequivocally that tau is indeed expressed in the lens cortex, we con-
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ducted parallel studies on tau transcripts and protein expression in wild type, αA-/--, αB-/--, and αA/B-/-- mouse brains.
This analysis is particularly relevant because αA- and αBcrystallin are also expressed at low levels in brain [5,6]. RT-

Figure 7. Quantitative RT-PCR analysis for tau transcripts in the lens.
Figure 6. Effect of age on tau expression in mouse lens. MicrotuA: Transcripts for GAPDH, Tau-2, Tau-4, and Tau-6 were amplified
bule-associated proteins were isolated from cortical fiber cells of 1from wild type, αA-/--, αB-/--, and αA/B-/-- lenses using the indicated
to 12-month-old mice. Lenses (16-20) from each of wild type (WT),
primers. The primers for mouse GAPDH were: forward primer, AAG
αA-/--, αB-/--, and αA/B-/-- mice were pooled at every age. Proteins
GTG AAG GTC GGA GTC AAC G, and reverse primer, GCT CCT
were analyzed by immunoblotting with KAM-305 antibody to full
GGA AGA TGG TGA TGG; product size, 252 bp. B: Quantitative
length brain tau, and quantified by densitometric analysis. WT (black
RT-PCR analysis was performed. Data are representative of three
bars); αA-/-- (red bars); αB-/-- (blue bars); αA/B-/--, (green bars).
independent experiments.
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PCR analysis using mouse tau gene primers showed the expression of all three tau transcripts in brain (Figure 8A). The
relative expression of tau transcript encoding the smallest tau
peptide was 10 fold higher in the brain as compared with lenses
of wild type mice. The ratio of tau-2/GAPDH was 11.2±1.7 in
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wild type brains as compared with 1.44±0.26 in the wild type
lenses. Furthermore, in contrast to the enhanced expression of
tau transcripts in αA-/-- and αA/B-/-- lenses as compared with
wild type, quantitative RT-PCR showed that there was no significant upregulation of tau transcripts in the brains of αA-/-and αB-/-- mice (Figure 8B). αA/B-/-- brains, unlike αA-/-- or
αB-/-- brains showed a marked reduction in the tau transcripts
(Figure 8B). We next analyzed the effect of gene knockout of
αA- and αB-crystallin on the expression of tau protein in the
brain. Immunoblot analysis of tau protein in brains from knockout mice as compared with wild types revealed changes in
relative distribution of the three murine tau isoforms in αA-/-and αB-/-- brains (Figure 9). This analysis was done by heating the samples to 85 °C in SDS-PAGE sample buffer to get
good resolution. Using the KAM antibody to full length brain
tau, tau was detected as three immunoreactive bands in the
wild type brain, but the smallest peptide band was undetectable in the αA-/-- and αB-/-- brains (Figure 9). Analysis of brain
fractions showed that the phosphorylation-dependent PHF-tau
antibody AT8 recognized mainly the highest molecular mass
tau peptide in wild type brain fractions (Figure 9). Quantitative analysis of the immunoblots with the PHF tau antibody
AT8 showed that the intensity of the smallest peptide increased
threefold in the αA-/-- and αB-/-- brain fractions. While some
variation between the different αB-/-- brain samples was noted,
statistical analysis showed that the increase in staining of the

Figure 9. Immunoblot analysis of tau in mouse brain. Brain MAPs
from 8-month-old wild type, αA-/--, and αB-/-- mice were prepared
and the proteins were separated by SDS-PAGE. Samples were heated
to 85 °C in SDS-PAGE sample buffer. Ten µg proteins were applied
to each lane. Immunoblot analysis was performed with the monoclonal antibody KAM-MA305 to full length brain tau protein and
the PHF-tau antibody AT-8. A: Wild type (Lane 1), αA-/-- (Lane 2),
and αB-/-- (Lane 3) brain MAPs. Note that three tau-immunoreactive
bands were readily detected in the wild type brains with the KAMMA305 antibody, but the smallest peptide was undetectable in the
αA-/-- and αB-/-- brains. B: Wild type (Lane 1), αA-/-- (Lane 2), and
αB-/-- (Lane 3) brain MAPs. Tau-immunoreactive bands were deFigure 8. Quantitative RT-PCR analysis for tau transcripts in the brain.
tected in the wild type brains with the PHF-tau AT-8 antibody. Note
that the only the largest immunoreactive peptide was strongly stained
A: Transcripts for GAPDH, Tau-2, Tau-4, and Tau-6 were amplified
from wild type, αA-/--, αB-/--, and αA/B-/-- lenses. B: Quantitative
in the wild type brain, but the immunoreactivity of the PHF-tau ATRT-PCR analysis was performed. Data are representative of three
8 antibody to the smaller tau peptide increased significantly in the
independent experiments.
αA-/-- and αB-/-- over wild type samples.
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smallest peptide in the αA-/-- and αB-/-- brain samples was significant (p=0.01). This antibody has been shown to recognize
tau protein phosphorylated at both serine 202 and threonine
205 of the longest human brain tau isoform [47]. These results suggest that gene deletion of αA- and αB-crystallin
caused an increase in phosphorylation of the tau epitope
Ser202/Thr205 in mouse brain. The phosphorylation-dependent antibody pS422 did not label mouse brain tau from wild
type or αA-/-- and αB-/-- samples (data not shown). We next
assessed tau staining in another mouse model for cataract by
UVB irradiation of mouse lenses in vivo (Figure 10). The UVB
irradiated lens showed vacuoles and opacities all over the lens
surface. Positive tau staining in the UVB-irradiated lens cortex was detected by immunofluorescence analysis, suggesting that tau upregulation is not restricted to the α-crystallin
knockout models.
DISCUSSION
The data presented in this investigation clearly establish the
expression of the brain MAP tau in the lens. Tau immunoreactivity was detected in the pool of microtubule associated proteins derived from lens cortical fiber cell microtubules of aged
in α-crystallin knockout mouse lenses. The localization of tau
immunoreactivity in the microtubule fraction is important since
it demonstrates that this microtubule associated protein local-
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izes to the same cellular fraction in the lens as in the brain
[52]. That tau accumulation is significant only in the cortical
fiber cells and not in epithelial cells of αA- and αB-crystallin
knockout lenses is attributable to the epithelial cells being able
to upregulate other mechanisms that may compensate for αcrystallin, whereas cortical fiber cells cannot [58,59]. These
findings expand the previously established developmentally
regulated expression of cargo vesicle transport proteins,
synapsins and synaptic vesicle proteins in lens [36].
The major tau transcript (Tau-2) was expressed even in
the wild type mouse lenses. The Tau-2 transcript was
upregulated several fold over wild type in the αA-/-- and αA/
B-/-- lenses. However, the tau protein (45-66 kDa) was in fact
not detected in the wild type lenses strongly suggesting that it
may be degraded in the wild type lenses. The tau protein was
upregulated in α-crystallin knockout lenses in an age-dependent manner, with significant accumulation restricted to the
cortical fiber cells of lenses derived from mice older than 6
months of age. Aging lens cortical fiber cells accumulate insoluble proteins, an increase in protein modifications, and a
reduction in levels of reduced glutathione, and experience increased oxidative damage [60]. Our data suggest that these
changes in the lens may enhance the accumulation of tau in
the α-crystallin knockout lenses. Our results contradict a previous report where tau expression was reported in lens as a 36
kDa protein in crude lens soluble and insoluble fractions [36].
Since the molecular mass of tau peptides is normally reported
to be 45-66 kDa, the protein at 36 kDa might be a cross-reacting protein in the crude lens preparation. While microtubule
motor protein expression has been reported in young rodent
lenses [61], it is not known at present whether their expression is age-dependent.
The cortical fibers where tau protein accumulated are particularly interesting because fiber cell changes in this region
have been associated with other cataract models including diabetic cataract in rodents [62]. The known ability of tau to enhance microtubule stability suggests that an increase in tau
expression may be a response of the lens to the reported increase in instability of the microtubule cytoskeleton in the
knockout lenses [42]. Indeed, αA- and αB-crystallin have been
shown to enhance the stability of microtubules, and protect
tubulin from denaturation [38,42].
One explanation for the observed increase in αB-crystallin in neurodegenerative diseases may be as a failed protective mechanism to suppress tau aggregation and to keep tau
proteins in a productive folding pathway. This mechanism may
modulate microtubule integrity and accumulation of tau aggregates in the form of neurofibrillary tangles, and αB-crystallin may therefore play a role in the pathogenesis of taurelated diseases [63]. There are at least 6 tau protein isoforms
expressed in the brain. In addition to the 45-66 kDa subunits,
the αB-/-- aged lens cortical fibers also expressed the high
molecular weight forms of tau (100 and 200 kDa) suggesting
that these might result from crosslinking and aggregation of
tau in the lens in the absence of αB-crystallin. It is known that
the αA- and αB-crystallin are anti-apoptotic proteins and protect cells from stress-induced death [40,64,65]. The pathogenic

Figure 10. Expression of tau immunoreactivity in UVB mouse cataract model. Shown are the untreated lens (A) and the UVB-treated
lens (B). Note the increase in lens cortical fiber cell immunostaining
of tau in the UVB cataract model. Six-month-old wild type mice
were exposed to 28 kJ/m2 UVB irradiation in vivo, and the eyes were
dissected and sectioned. Lens immunofluorescence was visualized
using the KAM antibody to tau, which was reactive in immunoblots.
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